Authors: BUSTO UE NARANJO CA BREMNER KE PEACHEY JE BOLOGA M

Citation: Ue. Busto et al., SAFETY OF IPSAPIRONE TREATMENT COMPARED WITH LORAZEPAM - DISCONTINUATION EFFECTS, Journal of psychiatry & neuroscience, 23(1), 1998, pp. 35-44

Authors: LAPIERRE YD SILVERSTONE P REESAL RT SAXENA B TURNER P BAKISH D PLAMONDON J VINCENT PM REMICK RA KROFT C PAYEUR R ROSALES D LAM R BOLOGA M

Citation: Yd. Lapierre et al., A CANADIAN MULTICENTER STUDY OF 3 FIXED DOSES OF CONTROLLED-RELEASE IPSAPIRONE IN OUTPATIENTS WITH MODERATE TO SEVERE MAJOR DEPRESSION, Journal of clinical psychopharmacology, 18(4), 1998, pp. 268-273

Authors: DIAVCITRIN O PARK YH VEERASUNTHARAM G POLACHEK H BOLOGA M PASTUSZAK A KOREN G

Citation: O. Diavcitrin et al., THE SAFETY OF MESALAMINE IN HUMAN-PREGNANCY - A PROSPECTIVE CONTROLLED COHORT STUDY, Gastroenterology, 114(1), 1998, pp. 23-28

Authors: BOULET LP TURCOTTE H LAVIOLETTE M COTE J WYILE G BOLOGA M

Citation: Lp. Boulet et al., INHIBITORY EFFECTS OF BAY X-7195, A CYS LEUKOTRIENE-1 RECEPTOR ANTAGONIST, ON ALLERGEN-INDUCED ASTHMATIC RESPONSES, Annals of allergy, asthma, & immunology, 79(2), 1997, pp. 155-161